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Exploration of morbidity, suicide and all-cause
mortality in a Scottish forensic cohort over 20 years
Cheryl Rees and Lindsay Thomson
Background
Premature mortality among patients experiencing forensic care
is high. This paper examines the morbidity and mortality of all
Scottish high secure patients in 1992/1993 and followed up 20
years later through the context of recovery.
Aims
To exploremorbidity and delineatewhich patients are at greatest
risk of premature mortality. To assess the extent of suicide and
unnatural deaths. To establish which factors, if any, appear
protective.
Method
Health andmortality data were extracted from national data-sets
and death categorised as premature or post-expected age.
Standardised mortality ratios were calculated to explore natural,
unnatural and suicide deaths with Cox regression conducted to
explore baseline demographics and premature death.
Results
During a mean follow-up of 21.1 years, 36.9% (n = 89) died, at an
average age of 55.6 years. Of these, 70.8% (n = 63) died
prematurely. Men lost on average 14.9 years and women 24.1
years of potential life. Five lives (5.6%) were lost by suicide and
three (3.4%) by unnatural means.
Conclusions
In contrast to other mainstream and forensic cohorts, high rates
of suicide and accidental deaths were not apparent. Risk of
prematuremortality is high. A greater focus upon physical health
by community and in-patient services is essential.
Keywords
Forensic mental health; premature mortality; unnatural death;
morbidity.
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Background
The elevated mortality risk associated with a diversity of mental dis-
orders when contrasted with the general population is an accepted
finding.1–3 The number of years of life lost in relation to all-cause
mortality varies from 7 to 24 depending on the nature of the condi-
tion.2 Substance use disorder (SUD) conveys the highest potential
number of years lost (9–24); however, this is closely followed by the
ranges for personality disorders (13–22 years), schizophrenia (10–
20 years) and bipolar disorder (9–20 years) demonstrating a psycho-
physiological influence (which we define as a physiological response
mediated by biochemical pathways to psychological distress) upon
morbidity/mortality beyond the physical impact of illicit substances.
In relation to dual diagnosis the risk of death among individuals
with severe mental illness (SMI) and concurrent SUD is in excess of
those with SMI alone.4 Evidence suggests all–cause mortality rates
for individuals with schizophrenia may also be increasing,1,5,6 but
high rates of suicide, particularly after discharge from psychiatric
hospital admissions7 and unnatural deaths8 do not entirely
account for the observed disparity in mortality compared with the
general population.1
All-cause mortality in forensic settings
Although research primarily focuses onmainstream services, higher
rates of all-cause mortality have also been reported within prison
settings where the burden of mental health is also in excess of
general population comparisons,9 with mortality risk further com-
pounded by the high prevalence of SUD reported among prison-
ers.10 Similar high rates of all-cause mortality are apparent among
the forensic psychiatry literature.11–13 In 2011, Clarke et al12
noted the deaths of 9.6% of their cohort (n = 595) over a
maximum 20-year follow-up, Fazel et al11 reported 29.9% of their
population (n = 6520) dying over a mean of 15.6 years and Coid
et al13 found 4.9% of their cohort (n = 409) died over a mean of
6.2 years. Although they report differing mortality rates they all
exhibit high rates of suicide, 32%, 22.7% and 50% of the reported
deaths, respectively. In addition, Fazel et al11 noted the death of
14.2% of their cohort and Clarke et al12 22.8% of deaths from acci-
dental/unnatural causes.
There is limited literature regarding morbidity/mortality among
forensic patients who represent a specific subset of individuals experi-
encing SMI.14 Findings from mainstream populations cannot be
safely generalised because of differing recovery and treatment path-
ways which, in the case of forensic patients, require to be balanced
against the risk to the public.15 To address this and from within the
context of recovery, a cohort from The State Hospital, Carstairs, the
high secure hospital for Scotland and Northern Ireland, has been
explored 20 years from their involvement in The State Hospital
Survey.16 As part of this follow-up morbidity and mortality has
been examined to explore influencing factors at a local level.
Aims
The aims of this paper are to:
(a) explore morbidity among this group;
(b) delineate which patients are at greatest risk of premature
mortality;
(c) assess the extent of suicide and unnatural deaths;
(d) establish which factors, if any, appear protective to cohort
members.
Method
Cohort
The State Hospital Survey16 identified a whole population cohort of
241 patients (male n = 213, mean age 36 years, female n = 28, mean
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age 32 years) resident in the high secure State Hospital, Carstairs, at
some point between 25 August 1992 and 13 August 1993. Detention
was under civil (n = 92, 38.2%) and criminal procedures (n = 149,
61.8%). Baseline data were collected from case notes and clinical
interview. At baseline, the mean lifetime psychiatric stay was 9.3
years (range: 0.08–45). Following the baseline study the mean
high security admission was 6.8 years (median 4.3, range: 0.09–
22.4). Individuals who were subject to restrictions on discharge,
excluding prison transfers (n = 81), experienced a mean 9.4 years
(median 6.1, range: 0.15–22.4) in high security. Non-restricted indi-
viduals and individuals who were prison transfers (n = 160) spent a
mean of 5.4 years (median 3.5, range: 0.09–22.4) in high security.
Additional detailed cohort characteristics have been reported
elsewhere.16
In 2014 follow-up was initiated with clinical and morbidity data
collected for a mean of 19.2 years and mortality data only, for a
mean of 21.1 years (median 25.1, range: 0.61–25.4) with 5093.61
person-years at risk (PYAR).
The authors assert that all procedures contributing to this work
comply with the ethical standards of the relevant national and insti-
tutional committees on human experimentation and with the
Helsinki Declaration of 1975, as revised in 2008. The study was
approved by South East Scotland Regional Ethical Committee 01,
reference 15/SS/0015. Supplemental approvals and the wider
study protocol are described elsewhere.17 Written informed
consent was obtained from all living participants.
Data sources
The Electronic Data Research and Innovation Service (eDRIS) uti-
lised the cohort’s unique Scottish Community Health Index (CHI)
numbers (CHI is a population register used for healthcare purposes)
to search the data-sets of National Services Scotland (NSS), the
Scottish Health data controller. NSS provided Scottish morbidity/
mortality information and emigration data. The National Health
Service Central Register (NHSCR), using full name and date of
birth, supplied UK mortality information and indicated general
practitioner registration out with Scotland. Robust mortality
status information was unavailable for seven individuals traced to
Northern Ireland and one individual who was overseas therefore
these eight male participants are classed as mortality status
unknown.
NSS provided date of death and ICD-9/10 codes for causes of
death. NHSCR corroborated that data and supplied all death certifi-
cate information, identified deaths undetected by NSS and deaths
within the rest of the UK. NSS provided ICD-9/10 codes recorded
during general hospital in-patient and day-case admissions
(Scottish Morbidity Record 01), event duration, partial date
(month/year) and admission type with data requested for all
deceased and consented individuals.
Years of birth for the deceased cohort were applied to the
expectation of life, by gender and selected age, Scotland, 1861 to
2011 table.18 Deaths were categorised as premature; defined as
dying before the age listed based on year of birth/closest period or
as post-expected, where death occurred at any point beyond the spe-
cified age. Using indirect standardisation19 we calculated standar-
dised mortality ratios (SMR) and 95% CI comparing the risk of
death among the cohort with the risk of death within the Scottish
population.
Data analysis
We used Cox regression analysis to examine variation in risk of pre-
mature death over time according to baseline characteristics. The
time in the study ran from 1 September 1992 (or recruitment to
baseline study) until 31 December 2017 or date of death. Cases of
individuals experiencing death post-expected age were filtered
from analysis. The eight individuals with mortality status
unknown were right censored20 with time in study as recruitment
until discharge from The State Hospital when they were lost to
follow-up. Independent variables were based upon previous litera-
ture and where preliminary analysis yielded statistically significant
results.
Kaplan–Meier plots were constructed for each covariate to
assess the assumption of proportional hazard. Where the assump-
tion was violated a time-dependent covariate was included. Cox
regression models were constructed for each covariate while con-
trolling for age at baseline. All analysis were conducted using
SPSS version 22.21
Results
Mortality
Eighty-nine individuals (36.9%) were deceased as of 31
December 2017 providing an all-cause crude death rate (CDR)
of 1747/100 000 PYAR (95% CI 1403–2150). At point of death:
51.7% (n = 46) were resident in the community, 30.3% (n = 27)
within low secure/open wards, 15.7% (n = 14) in high security
and 2.2% (n = 2) were detained in prison.
Mean age of death was 55.6 years (range: 30.5–84.7). Seventy-
seven (36.2%) men died and 12 (42.9%) women at average ages of
56.6 years (range: 30.5–84.7) and 48.9 years (range: 36.2–66.1)
respectively.
Table 1 outlines mortality status by primary diagnosis. As
detailed in Table 2, 52 (67.5%) men died prematurely, and 11
(91.7%) women died prematurely. The mean years of potential
life lost were 14.9 years (range: 0.09–35.7) for the men and 24.1
years (range: 5.2–35.8) for the women (10 women; one woman
was born, lived primarily and died overseas). Excluding prison
transfers, 22.2% (n = 18/81) prematurely deceased individuals
were subject to restrictions at baseline (specific mortality rate
1052/100 000 PYAR, 95% CI 623–1663) with 28.1% (n = 45/160)
non-restricted individuals having prematurely died (specific mor-
tality rate 1330/100 000 PYAR, 95% CI 970–1780).
The SMRs by gender are detailed in Table 3. The SMR for all-
cause deaths (SMR = 397, 95% CI 321–487) indicates a mortality
rate almost four times that observed within the Scottish population.
The ratio for the males (SMR = 297, 95% CI 236–370) returns a
threefold increase in mortality whereas the females exhibit an
SMR (SMR = 1000, 95% CI 542–1700) ten times the population
rate. A high proportion of deaths (91.0%) occurred as a result of
natural causes (SMR = 401, 95% CI 321–496).
Suicide was defined by explicit codes; E950–959 (ICD-9) and
X60–X84 (ICD–10). In addition, National Records Scotland
include ‘event of undetermined intent’ among probable suicides.
There were five suicides representing 5.6% of the 89 deaths (CDR
98/100 000 PYAR, 95% CI 32–229). Suicide mortality (SMR 625,
95% CI 229–1385) was six times the population rate. Accidental
deaths occurred in three individuals (3.4%) (SMR = 375, 95% CI
95–1021) at almost four times the population rate. Re-categorising
substance misuse deaths (n = 4, 4.5%) as accidental raises unnatural
mortality to almost nine times (SMR = 875, 95% CI 382–1731) the
population rate.
Cause of death
Underlying cause of death was assessed using ICD-9/10 classifica-
tions and categorised as premature/post-expected age as detailed
in Table 4. Premature death occurred in 63 (70.8%) people. The
primary cause of premature death (n = 20, 31.7%) was respiratory
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Table 2 Death categories by gender
Death Category Men, deceased (years) Women, deceased (years)
n (%) Mean age (range) n (%) Mean age (range)
Post-expected age 25 (32.5) 69.1 (61.3–84.7) 1 (8.3) 66.1 (66.1)
Premature death 52 (67.5) 50.6 (30.5–64.3) 11 (91.7) 47.4 (36.2–63.5)
Total 77 (100) 56.6 (30.5–84.7) 12 (100) 48.9 (36.2–66.1)
Table 1 Mortality status by primary diagnosis at baseline
Status at follow-up n (%) Total n (%) Specific mortality ratea (95% CI)
Alive Dead Unknown
Primary diagnosis (baseline)
Schizophrenia 94 (55.6) 71 (42.0) 4 (2.4) 169 (70.1) 2007 (1567–2532)
Depression 4 (66.7) 1 (16.7) 1 (16.7) 6 (2.5) 847 (21–4718)
Mania 1 (50.0) 1 (50.0) 0 (0) 2 (0.8) 2773 (70–15 451)
Antisocial personality disorder 6 (46.1) 6 (46.1) 1 (7.7) 13 (5.4) 2367 (869–5152)
Alcoholism/drug misuse 3 (60.0) 2 (40.0) 0 (0) 5 (2.1) 1817 (220–6566)
Intellectual disability 27 (84.4) 5 (15.6) 0 (0) 32 (13.3) 657 (213–1532)
Organic brain syndrome 3 (75.0) 1 (25.0) 0 (0) 4 (1.7) 1109 (28–6181)
Undiagnosed psychiatric illness 6 (66.7) 1 (11.1) 2 (22.2) 9 (3.7) 544 (14–3029)
None 0 (0) 1 (100) 0 (0) 1 (0.4) –b
Comorbid diagnosis (baseline)
Antisocial personality disorderc 39 (59.1) 26 (39.4) 1 (1.5) 66 (28.9) –
Heavy alcohol use/misuse 72 (61.5) 40 (34.2) 5 (4.3) 117 (48.5) –
Substance use 73 (64.6) 37 (32.7) 3 (2.7) 113 (46.9) –
Total n (%) 144 (59.8) 89 (36.9) 8 (3.3) 241 (100) –
a. Specific mortality rate per 100 000 person-years at risk.
b. Not calculated due to small group size/person-years at risk.
c. Antisocial personality disorder was the only comorbid personality disorder noted at baseline.
Table 3 Standardised mortality ratios (SMR) by nature of death and baseline demographics
Observed deaths Expected SMR Lower CI 95% Upper CI 95% P
All cause
Overall 89 22.4 397 321 487 <0.001
Male 77 25.9 297 236 370 <0.001
Female 12 1.2 1000 542 1700 <0.001
Natural
Overall 81 20.2 401 321 496 <0.001
Male 71 22.9 310 244 389 <0.001
Female 10 1.1 909 462 1620 <0.001
Unnatural
Overall 3 0.8 375 95 1021 n.s.
Male 2 1.1 180 30 600 n.s.
Female 1 0.04 2500 130 12330 <0.05
Suicide
Overall 5 0.8 625 229 1385 0.001
Male 4 1.5 267 85 643 n.s.
Female 1 0.05 2000 100 9864 <0.05
Age bands, years
15–44 18 3.7 487 297 754 <0.001
45–64 52 12.8 406 307 529 <0.001
≥65 19 5.9 322 200 494 <0.001
Diagnosis
Schizophrenia
All 71 15.8 449 354 563 <0.001
Male 62 18.2 341 263 434 <0.001
Female 9 0.9 1000 488 1835 <0.001
Intellectual disability
All 5 2.7 182 67.9 411 n.s.
Male 5 3.4 147 53.9 326 n.s.
Female 0 0.05 . . .
Dissocial personality disorder
All 6 1.7 361 147 752 <0.05
Male 4 1.8 224 71 539 n.s.
Female 2 0.18 1111 186 3671 <0.01
n.s., not significant.
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disease/cancer, with circulatory disease/events (n = 12, 19.0%)
forming the next largest group with other cancers responsible for
11.1% (n = 7). There were no significant differences between prema-
ture and post-expected age deaths by cause.
As noted there were n = 5 suicides. For these people baseline
primary diagnoses were mixed: three had schizophrenia, one had
antisocial personality disorder (ASPD) and one alcoholism. One
had comorbid ASPD. At baseline four reported a history of
heavy/abusive alcohol misuse and all confirmed polysubstance
drug use. At death, two were under mental health legislation, four
lived in the community and one in a low secure ward. All accidental
deaths occurred in the community, two because of assault and one
asphyxiation with food.
Statistical analysis
Cox regression analysis (Table 5) suggests that men detained under
civil provisions at baseline are more likely to die prematurely than
those detained under criminal provisions. Males experience a
lower risk of premature death and higher survival than females.
Diagnosis of intellectual disability at baseline is associated with
lower hazard and increased survival. Being female and having a
Table 4 Underlying cause, gender and death categorisation of deceased group
Cause of death (underlying) Death category
Premature, n (%) Post-expected age, n (%) All deaths, n (%) Pa
Respiratory disease (including bronchopneumonia) 11 (17.5) 6 (23.1) 17 (19.1) n.s.
Respiratory cancer 9 (14.3) 6 (23.1) 15 (16.9) n.s.
Circulatory disease/event 12 (19.0) 7 (26.9) 19 (21.3) n.s.
Cancer (other) 7 (11.1) 4 (15.4) 11(12.4) n.s.
Infection (including hepatitis, HIV and sepsis) 5 (7.9) 1 (3.8) 6 (6.7) n.s.
Other natural causes, for example renal failure, peritonitis 4 (6.3) 1 (3.8) 5 (5.6) n.s.
Drug/alcohol dependence 4 (6.3) 0 (0) 4 (4.5) n.s.
Suicide/undetermined intent 5 (7.9) 0 (0) 5 (5.6) n.s.
Traumatic death (unnatural) 3 (4.8) 0 (0) 3 (3.4) n.s.
Ill-defined or undetermined cause (natural) 3 (4.8) 1 (3.8) 4 (4.5) n.s.
Total 63 (100) 26 (100) 89 (100) n.s.
n.s., not significant.
a. Pearson’s χ2-test (Fisher’s exact test): premature/post-expected age.
Table 5 Hazard ratios (95% CI) for premature death by baseline demographics, adjusted for age at start of study
Adjusted hazard ratio (95% CI)a P
Unadjusted absolute
risk reduction (95% CI)b
Mental Health (Scotland) Act 1984
Civil detention (all) 1.80 (1.00–3.23) 0.05 0.12 (–0.24 to 0.01)
Civil detention (female) 0.57 (0.17–1.96) n.s. 0.13 (–0.23 to 0.50)
Civil detention (male) 2.13 (1.17–3.88) 0.01 −0.15 (–1.67 to –0.07)
Criminal detention 1 – Reference
Sex
Female 0.41 (0.18–0.96) 0.04 −0.13 (–0.33 to 0.07)
Male 1 – Reference
Any intellectual disability diagnosis
Intellectual disability diagnosis (all) 0.27 (0.08–0.87) 0.03 0.20 (0.07 to 0.33)
Intellectual disability diagnosis (female) 0.04 (0–333.2) n.s. 0.44 (0.25 to 0.63)
Intellectual disability diagnosis (male) 0.31 (0.10–1.01) 0.05 0.17 (0.04 to 0.31)
No Intellectual disability diagnosis 1 – Reference
Schizophrenia diagnosis
Schizophrenia diagnosis (all) 1.98 (0.92–4.28) n.s. –0.14 (–0.26 to –0.02)
Schizophrenia diagnosis (female) 1.34 (0.36–5.06) n.s. –0.11 (–0.50 to 0.27)
Schizophrenia diagnosis (male) 2.27 (0.95–5.45) n.s. –0.15 (–0.27 to –0.02)
No schizophrenia diagnosis 1 – Reference
Comorbid diagnosis dissocial personality disorder (DPD)
Comorbid DPD (all) 1.07 (0.49–2.35) n.s. –0.05 (–0.19 to 0.09)
Comorbid DPD (female) 8.36 (1.38–50.73) 0.02 –0.37 (–0.81 to 0.06)
Comorbid DPD (male) 0.97 (0.53–1.78) n.s. 0.01 (–0.15 to 0.13)
No comorbid DPD diagnosis 1 – Reference
Medication
Depot neuroleptics at baseline (all) 1.98 (0.99–3.93) 0.05 –0.17 (–0.29 to –0.05)
Depot neuroleptics at baseline (female) 2.34 (0.51–10.87) n.s. –0.22 (–0.60 to 0.15)
Depot neuroleptics at baseline (male) 3.69 (1.11–12.22) 0.03 –0.16 (–0.29 to –0.04)
No depot neuroleptics 1 – Reference
Substance misusec
Drug misuse recorded (all) 3.71 (1.30–10.58) 0.01 –0.14 (–0.27 to –0.02)
Drug misuse recorded (female) 3.5 (0.41–29.54) n.s. –0.25 (–0.62 to 0.13)
Drug misuse recorded (male) 3.44 (1.02–11.61) 0.05 –0.13 (–0.26 to 0.01)
No recorded drug misuse 1 – Reference
a. Adjusted for age at baseline.
b. Compared with appropriate ‘control’ group. Negative value, absolute risk increase.
c. Any drug misuse or heavy alcohol/misuse reported at baseline.
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comorbid diagnosis of ASPD significantly increased the likelihood
of premature death, a finding not replicated in the males. In
general, and for the males, receiving antipsychotic medication by
depot injection was associated with higher hazard and shorter sur-
vival. Substance misuse at baseline (alcohol misuse or illicit drug
use) was significantly associated with an increased hazard of prema-
ture death both overall and among males.
Morbidity
Data relating to Scottish general hospital in-patient admissions for
the 89 deceased and 66 consented participants were obtained from
NSS (n = 154 as one participant died following consent). A nil
return was obtained if the individual had never had a general hos-
pital in-patient admission in Scotland between baseline and 31
December 2014/date of death. Data were acquired for 115, with a
further 39 individuals receiving a nil return. Table 6 reports the
mean number of unique ICD-10 codes allocated for each ICD-10
block. Table 7 outlines the number of individuals in receipt of an
ICD-9/10 classification by ICD-10 block description and Table 8
the number of days spent as a general hospital in-patient.
Examination of the tables presented provides an overview of the
physical health of the alive, prematurely deceased and post-expected
age deceased groups. No significant differences were observed in
terms of mean endocrine, nutritional and metabolic disease diagno-
ses between the living participants and those who prematurely died.
Similarly, no significant differences were observed for diseases of the
circulatory system. In relation to respiratory system diseases, a sig-
nificant difference was observed in mean diagnoses between prema-
turely deceased (1.44 diagnoses, P = 0.002) and living participants
(0.48 diagnoses). In terms of ICD-10 blocks S–Y ‘Injury, poisoning
& certain other consequences of external causes’, a significant differ-
ence was observed between prematurely deceased (4.05 diagnoses,
P = 0.005) and living participants (1.31 diagnoses). Unfortunately,
injuries resulting from self-harm cannot be distinguished from
accidental harm. Prematurely deceased individuals received signifi-
cantly more diagnoses (11.59, P = 0.022) compared with consented
participants (5.8 diagnoses).
Those who died prematurely spent on average significantly
more days as general hospital in-patients in relation to total
trauma (14.1 days, P = 0.007), urgent (12.4 days, P = 0.011) and
routine admissions (15, P < 0.001) than living participants.
Discussion
This study investigated morbidity and mortality findings from a 20-
year follow-up of a cohort of high secure forensic patients first
recruited as a whole population survey and followed through the
context of recovery.
Unnatural and suicide deaths
In stark contrast to previously reported forensic6,22 and mainstream
psychiatric findings2,23 we did not observe exceptional rates of
suicide and accidental/unnatural deaths. We described a sixfold
(SMR = 625) increase in suicide and an almost fourfold (SMR =
375) increase in unnatural deaths against the general population.
In comparison, Clarke et al12 reported a SMR for suicide of 3231,
and for all unnatural deaths of 1898 in relation to a cohort followed
for a maximum of 20 years (n = 595, 5593 PYAR) after first admis-
sion to a medium secure unit. Including the few drug/alcohol deaths
within accidental (unnatural) deaths we only returned an almost
ninefold increase. No suicide/accidental deaths occurred within
high secure care, and only one of our eight suicide/accidental
deaths happened within the psychiatric hospital environment. Of
the n = 31 suicide/open verdicts and accidental deaths reported by
Clarke et al12 almost half (n = 15) the preventable deaths occurred
within high/medium security and the wider hospital environment.
Table 6 Mean number of ICD-10 codes allocated for each ICD-10 block
ICD-10 Blocks Alive (n = 65)
Premature death
(n = 63)
Post-expected age
(n = 26) Total (n = 154) Pa
Mean
s.d. (min–
max) Mean
s.d. (min–
max) Mean
s.d. (min–
max) Mean
s.d. (min–
max)
A/B –Certain infectious and parasitic diseases 0.12 0.4 (0–2) 0.44 1.0 (0–6) 0.23 0.6 (0–2) 0.27 0.8 (0–6) 0.027
C/D – Neoplasms 0.14 0.6 (0–3) 0.33 0.7 (0–3) 0.54 0.8 (0–2) 0.29 0.7 (0–3) 0.009
D – Diseases of blood and blood forming organs/
certain disorders of immune mechanism
0.12 0.4 (0–2) 0.16 0.4 (0–1) 0.19 0.5 (0–2) 0.15 0.4 (0–2) n.s.
E – Endocrine, nutritional and metabolic diseases 0.18 0.5 (0–2) 0.27 0.6 (0–3) 0.46 0.7 (0–2) 0.27 0.6 (0–3) n.s.
G – Diseases of the nervous system 0.14 0.5 (0–3) 0.43 0.8 (0–3) 0.54 0.9 (0–4) 0.32 0.7 (0–4) 0.005
H – Diseases of the eye and adnexa/ear and mastoid
process
0.14 0.5 (0–2) 0.1 0.4 (0–2) 0.19 0.5 (0–2) 0.13 0.4 (0–2) n.s.
I – Diseases of the circulatory system 0.26 0.6 (0–2) 0.59 1.6 (0–11) 1.23 1.3 (0–4) 0.56 1.2 (0–11) n.s.
J – Diseases of the respiratory system 0.48 1.0 (0–4) 1.44 2.1 (0–9) 1.42 2.0 (0–8) 1.03 1.8 (0–9) 0.002
K – Diseases of the digestive system 1.25 2.2 (0–9) 1.32 1.9 (0–10) 0.65 1.2 (0–5) 1.18 1.9 (0–10) n.s.
L – Diseases of the skin and subcutaneous tissue 0.25 0.6 (0–3) 0.37 0.7 (0–3) 0.19 0.5 (0–2) 0.29 0.7 (0–3) n.s.
M – Diseases of the musculoskeletal system and
connective tissue
0.09 0.3 (0–2) 0.32 0.9 (0–5) 0.31 0.8 (0–3) 0.22 0.7 (0–5) n.s.
N – Diseases of the genitourinary system 0.38 0.8 (0–4) 0.41 1.3 (0–8) 0.85 1.9 (0–8) 0.47 1.3 (0–8) n.s.
O/P – Pregnancy childbirth and the puerperium/
Perinatal period)
0 0 (0) 0.02 0.1 (0–1) 0 0 (0) 0.01 0.1 (0–1) n.s.
Q – Congenital malformations deformations and
chromosomal abnormalities
0.03 0.2 (0–2) 0.03 0.3 (0–2) 0 0 (0) 0.03 0.2 (0–2) n.s.
R – Symptoms, signs and abnormal laboratory findings
not elsewhere classified
0.94 1.9 (0–12) 1.32 2.5 (0–14) 1.96 3.0 (0–11) 1.27 2.4 (0–14) n.s.
S–Y – Injury, poisoning & certain other consequences
of external causes (includes V–Y and U codes)
1.31 4.0 (0–22) 4.05 9.0 (0–49) 1.12 1.5 (0–5) 2.4 6.5 (0–49) 0.005
Total ICD–10 blocks 5.8 9.4 (0–54) 11.59 15.6 (0–66) 9.88 9.7 (0–33) 8.86 12.6 (0–66) 0.022
Min–max, minimum–maximum; n.s., not significant.
a. Mann–Whitney U-test, alive/premature death.
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We considered a number of factors in exploring this finding of a
low rate of suicide and accidental deaths within our cohort. First,
was the Scottish suicide rate lower than elsewhere in the UK? The
2018 Scottish suicide rate (16.1/100 000 persons) was greater than
the comparably reported English rate (10.3/100 000).24 Therefore
Scotland does not have a naturally low rate of suicide.
Second, was our low rate of suicide reflected in the general adult
psychiatry population in Scotland? This was refuted by a historical
Scottish population study of discharged, long-term (>1 year) psy-
chiatric in-patients that reported an increased suicide risk 13
times the population rate.25
Third, was the diagnostic profile of this Scottish cohort impact-
ful? Unlike other UK regions,13 within Scotland offenders with a
primary diagnosis of personality disorder generally remain within
the criminal justice system. At baseline only 5% received a primary
diagnosis of personality disorder whereas 70% attracted a schizophre-
nia diagnosis. This compares with 25.8% of individuals with person-
ality disorder in a Swedish forensic cohort,11 26.6% in an English
medium secure cohort12 and 13.5% in an English community
cohort.13 Only the Clarke et al12 study splits suicide between
mental illness and psychopathy at 72.2% and 16.6%, respectively,
which is reduced in the personality disorder group given that it
was 26.6% of their cohort. The different diagnostic profiles may
be a factor in explaining our findings but this is not supported by
the Clarke et al12 study and would not account for the extent of
the difference. Suicide rates are generally high among individuals
experiencing personality or psychotic disorder26 with risk of
accidental death higher for personality disorder compared with
schizophrenia.8 Contextualising our suicide deaths within our
diagnostic profile we observe a similar pattern; 60% of people who
died by suicide had schizophrenia at baseline, one person had
ASPD and another alcoholism. A total of 80% were male and the
same proportion had a history of heavy/abusive alcohol use, all
displayed polysubstance drug misuse, known risk factors for
non-natural death.26 That description differs from the overall
cohort, 47% of whom reported substance misuse at baseline and
29% had comorbid ASPD.
Fourth, does the year the cohort was established or the length of
follow-up influence findings? Compared with other studies11–13 our
cohort was followed for the longest time therefore increasing rather
than decreasing suicide likelihood. Alternatively, have more
recently established cohorts observed behavioural change, making
suicide/accidental in-patient death more likely? Only one suicide
has been noted in our cohort source hospital (The State Hospital)
Table 7 Number of individuals in receipt of an ICD-10 classification by block description
Alive,
n (%)
Premature death,
n (%)
Dead (post-expected age),
n (%)
Total,
n (%)
Pa,b
(2 tailed)
ICD-10 blocks/codes (total n) n = 65 n = 63 n = 26 n = 154
Zero in-patient days/day surgery events 19 (29.2) 15 (23.8) 5 (19.2) 39 (25.3) –
A/B – Infectious diseases 7 (10.8) 16 (25.4) 4 (15.4) 27 (17.5) 0.039
C00 –D48 neoplasms 4 (6.2) 15 (23.8) 10 (38.5) 29 (18.8) 0.006
D – Blood/immune 7 (10.8) 10 (15.9) 4 (15.4) 21 (13.6) n.s.
E – Endocrine/metabolic/ nutritional disease 9 (13.8) 12 (19.0) 9 (34.6) 30 (19.5) n.s.
G – Nervous system disease 5 (7.7) 17 (27.0) 10 (38.5) 32 (20.8) 0.005
H – Eye/ear disease 6 (9.2) 4 (6.3) 4 (15.4) 14 (9.1) n.s.
I – cardiovascular disease 13 (20.0) 18 (28.6) 15 (57.7) 46 (29.9) n.s.
J – Respiratory disease 17 (26.2) 30 (47.6) 15 (57.7) 62 (40.3) 0.017
K – GI disease 30 (46.2) 32 (50.8) 8 (30.8) 70 (45.5) n.s.
L – Skin/subcutaneous tissue disease. 10 (15.4) 16 (25.4) 4 (15.4) 30 (19.5) n.s.
M – Musculoskeletal connective tissue disease 5 (7.7) 10 (15.9) 4 (15.4) 19 (12.3) n.s.
N – Genitourinary disease 13 (20.0) 12 (19.0) 7 (26.9) 32 (20.8) n.s.
Any pregnancy-related disorder 0 (0.0) 1 (1.6) 0 (0.0) 1 (0.7) n.s.
Q – Any congenital/chromosomal etc. disorder 1 (1.5) 1 (1.6) 0 (0.0) 2 (1.3) n.s.
R – Abnormal clinical findings 28 (43.1) 31 (49.2) 15 (57.7) 74 (48.1) n.s.
S–Y – Injury, poisoning & certain other consequences of
external causes
14 (21.5) 28 (44.4) 12 (46.2) 54 (35.1) 0.008
Obesity 1 (1.5) 2 (3.2) 2 (7.7) 5 (3.2) n.s.
Type 2 diabetes 5 (7.7) 6 (9.5) 3 (11.5) 14 (9.1) n.s.
Respiratory cancer 0 (0) 6 (9.5) 6 (23.0) 12 (7.8) 0.013
Non-respiratory cancer 1 (1.5) 4 (6.3) 2 (7.7) 7 (4.5) n.s.
Alcohol 5 (7.7) 8 (12.7) 2 (7.7) 15 (9.7) n.s.
Drug 0 (0) 5 (7.9) 0 (0) 5 (3.2) 0.027
Tobacco 2 (3.0) 8 (12.7) 4 (15.4) 14 (9.1) n.s.
Min–max, minimum–maximum; n.s., not significant.
a. Pearson’s χ2 test (Fisher’s Exact test): Alive/ premature death.
b. ICD-10 blocks/codes.
Table 8 Mean days spent within the general hospital in-patient environment
General hospital in-patient days
Alive (n = 65)
Premature death
(n = 63)
Dead (post-expected
age) (n = 26) Total (n = 154)
Mean s.d. (min–max) Mean s.d. (min–max) Mean s.d. (min–max) Mean s.d. (min–max) Pa
Total trauma related 0.49 2.1 (0–15) 14.14 71.1 (0–555) 1 2.6 (0–13) 6.16 45.8 (0–555) 0.007
Total urgent days 3.38 8.5 (0–53) 12.4 28.8 (0–197) 8.08 11.7 (0–40) 7.86 20.1 (0–197) 0.011
Total routine days 3.69 11.2 (0–56) 15 39.5 (0–289) 26.27 48.5 (0–164) 12.13 33.7 (0–289) <0.001
Total in-patient days 7.57 19.5 (0–121) 41.54 133.1 (0–1041) 35.35 51.8 (0–184) 26.16 89.6 (0–1041) <0.001
Min–max, minimum–maximum.
a. Mann–Whitney U-test: alive/premature death.
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since 1996 (email from Health Records, The State Hospital, tsh.
Health_Records@nhs.net, November 2019).
Finally, is engagement with the Scottish forensic mental health
system protective against suicide or accidental death? An examin-
ation of suicides (n = 14) occurring within high secure care in
Scotland (The State Hospital, 1972–1996)27 noted treatment-resist-
ant schizophrenia and having committed violent offences as suicide
risk factors. Greater liberalisation of the hospital, increased activities
and reintroduction of clozapine were suggested for the suicide
reduction observed over time. This continuing developmental
process alongside estate renewal may influence our observed low
suicide/accidental death rate while patients resided in high secure
care. At death two individuals were under mental health legisla-
tion/restrictions. Examining CDR figures, restrictions made little
difference to the premature death rate. Also considered was if a
longer period of contact and mandated relationship with services
may protect against suicide; alternatively, lack of autonomy may
be a negative influence. Neither was apparent within our findings.
We hypothesise that factors within the Scottish forensic in-
patient environment; physical, procedural and/or relational are pro-
tective in terms of suicide prevention or in deterring behaviour
leading to accidental death and that these may have an ongoing
effect on patients’ relationships with services in the community.
There may also be organisational factors that reduce avoidable
deaths. Scottish forensic services have advantages in terms of size
and cohesion, with few independent secure beds, and the strategic
lead of the Forensic Network.
Risk of premature mortality
A large proportion of our cohort died (36.9%) demonstrating an
almost fourfold increase (SMR = 397) in all-cause mortality. This
represents a slightly higher CDR than reported for forensic services
in England/Wales,22 mirrors an English general adult community-
recruited cohort experiencing psychosis28 and is lower than
reported internationally.22 In contrast, 91% of our cohort died of
natural causes four times (SMR = 401) the rate of the general popu-
lation. Natural deaths within the discharged Scottish general adult
psychiatry in-patient population has been reported at SMR =
16929 indicating a difference in mortality between Scottish forensic
and general adult in-patients.
Overall, 70.8% of deaths were premature and naturally occur-
ring at an average age 55.6 years. Respiratory disease/cancer was
the underlying cause of almost a third of premature and 36% of
all deaths, with cardiovascular disease related to 19% of premature
and 21% of all mortality. Study recruitment occurred during 1992/3
when almost all patients smoked or were passive smokers. Since
December 2011, our cohort source hospital, The State Hospital,
Carstairs has been entirely smoke free.
Rates of respiratory related deaths, in excess of fourfold the
expected level have been noted in an early population study of dis-
charged Scottish general adult psychiatry long-term (>1 year) in-
patients25 with rates of death related to cardiovascular disease
being slightly raised at SMR = 160. A later examination29 capturing
all discharged general adult psychiatric in-patients reported that
cardiovascular disease, despite displaying only a small rise in relative
risk (SMR = 170) was responsible for 67% of total mortality and 54%
of the total years of potential life lost. A similar English study exam-
ining death within a year of discharge of patients with schizophrenia
reported SMR of 470, and 250 for respiratory and circulatory disease
deaths, respectively, with increased rates from 1999 to 2006.6
The cohort of 28 females represents around 50% of Scottish
female forensic patients, reported as n = 56 in 200430 and n = 60
in 2017.31 There is an obvious disparity between the male and
female groups. Almost all women died prematurely aged under 48
years with mean loss of 24 years of potential life. Their SMR for
natural death was three- to fourfold the male rate and that held
for females with schizophrenia, rising to fivefold for a primary diag-
nosis of ASPD. Receiving a comorbid diagnosis of ASPD was also
associated with premature death. This suggests that ASPD may
have a unique impact on the physical health of women in a
manner not reflected in risky behaviour or suicide completion.
There is a lack of published literature regarding gender differ-
ences in mortality among patients located within forensic services
with papers and reviews generally commenting on the percentage
of males within the cohort.13,22 Where data does exist,12 our results
replicate those findings, namely that SMR for death because of
natural causes, unnatural causes and suicide are higher for the
female than the equivalent male cohort. However, as with those pre-
sented here, findings must be interpreted with caution because of the
extreme gender imbalance evident within forensic psychiatric services
and reflected in small numbers of females in research cohorts.
A similar picture has, however, been observed within main-
stream services, specifically in relation to individuals with schizo-
phrenia. A population follow-up of all in-patients admitted with
schizophrenia diagnosis from 1980 to 2006 indicated that up to
1992 the SMR for males in relation to all-cause, unnatural and
natural deaths exceeded that of females; however, for individuals
admitted post 1992 the opposite was observed: females displayed
greater all-cause, unnatural and natural SMR.32 More recently an
American population study reported that female SMR for all-
cause mortality exceeded the male equivalent; however, the SMR
for unnatural death was higher among males.5
Almost 68% of males died prematurely at mean age 50 years.
Males detained under civil measures were significantly more likely
to die prematurely than those males under criminal procedures.
Similarly, males in receipt of depot antipsychotics at baseline were
significantly more likely to have died prematurely. It is conceivable
that as civil patients transfer to high secure care because of acute
morbid positive symptoms and/or locally unmanageable levels of
violence or aggression16 and by utilising depot medication as a
proxy for illness severity, we may be observing those who experi-
enced the severest symptoms and psychological distress, dying pre-
maturely. Specifically, that is, individuals who may be more greatly
influenced by psychophysiological factors.
Scottish forensic services acknowledge that female patients
represent a heterogeneous group, often more chaotic and challen-
ging with differing needs to male patients,30 with higher rates of
mortality33 and generally poorer outcomes.34 Although Scotland
lacks female high secure care and exclusively single gender
medium secure provision (with some services provided within
England), because of the general complexity of female patients, pro-
viding appropriate relational security and support can be more
important than physical security.31 Regardless of shortcomings in
the Scottish female forensic estate, the high levels of premature mor-
tality of both genders cannot be overlooked.
Despite spending on average longer as high secure in-patients,
with exposure to the health benefits that offers, there was little differ-
ence in CDR for those subject to restrictions on discharge and those
not. Fazel et al22 pointed out that mortality rates among forensic in-
patients are high but more closely reflect the general adult psychiatry
population than prisoners. They postulate that greater than any
factors negatively influencingmortality within forensic environments
are the poor lifestyle choices evident among general psychiatric popu-
lations that can compound psychotropic medication side-effects.
Given our respiratory findings, however, the impact of a heavy
smoking environmentmust be acknowledged.Althoughpoor lifestyle
choices have an impact on morbidity/mortality among individuals
experiencing SMI again the increased morbidity risks and resultant
mortality are not fully explained by behavioural patterns.35,36
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Protective factors
Within this cohort some protective factors appeared evident.
Although both genders died at early ages the males lived on
average almost 8 years longer compared with the females. Males
with a primary diagnosis of intellectual disability appeared less
likely to die (SMR = 147, 95% CI 53.9–326) and it could be that
those patients with intellectual disability received less psychotropic
medication and accompanying side-effects. One reason suggested
for high rates of morbidity among individuals with mental ill
health is the propensity for diagnostic overshadowing to occur.
This is when disparities occur in the treatment and diagnosis of phys-
ical disorders as a result of misattribution of physical symptoms to
mental illness.37 Although we interpreted experiencing primary intel-
lectual disability as a protective factor, diagnostic overshadowing has
been presented as a particular problem within the intellectual disabil-
ity population with symptoms related to physical or mental ill health
being misattributed to their intellectual disabilitiy.38 We suggest that
in line with our assertion that engagement with the Scottish forensic
mental health system may be protective against unnatural death and
death by suicide, for individuals with intellectual disability, location
within services almost exclusively under National Health Service
operational control may confer advantages to forensic patients with
intellectual disability in terms of staffing, their training and support
and patient services offered. Higher levels of in-patient and commu-
nity support to avoid offending and foster appropriate behaviourmay
also reduce stress and encourage patients with intellectual disability to
adopt heathier lifestyles, with a potential reduction in drug and
alcohol use. More attention may be paid to their physical health by
staff, and general practitioner referrals encouraged and supported,
leading to earlier physical health intervention and a reduction in diag-
nostic overshadowing.
It is also acknowledged that individuals with intellectual disabil-
ity represent a particularly vulnerable subpopulation within the
prison environment, being subject to high rates of mental disorder39
and possibly greater risk of suicidal ideation than the general popu-
lation.40 We propose that a contributing factor to this poor outlook
is a lack of equivalence, equality and equity for people with intellec-
tual disability within the UK prison system.41 Again we propose that
our intellectual disability cohort were protected from premature
mortality precisely because they were, where appropriate, diverted
from the prison environment and supported by specialist forensic
psychiatric services within hospital and community settings,
designed to promote and provide equality of life experience.
Further research is required to address the paucity of literature
robustly identifying and exploring the journey of individuals with
intellectual disability through services.
Morbidity
Antipsychotic medications, a reliable mechanism for easing symp-
toms, reducing distress and therefore enhancing recovery carry
with them a diversity of side-effects: activating, sedating and meta-
bolic. Unsurprisingly antipsychotics have been targeted as a possible
reason for the premature mortality associated with schizophre-
nia.1,42 Population studies43 indicate that individuals with schizo-
phrenia treated with antipsychotics or antidepressants have a
lower risk of death compared with individuals not receiving such
medications. A primary diagnosis of schizophrenia was applied to
70% of this cohort, and receiving depot neuroleptics was signifi-
cantly associated with premature death; however, there were no sig-
nificant differences in mean diagnoses of cardiovascular or
endocrine, nutritional and metabolic disease applied to the living
participants and the prematurely deceased. What is apparent is
the significant difference in terms of respiratory disease, with
those dying prematurely receiving more diagnoses. Although
undoubtedly the legacy of an era, smoking remains an issue for
forensic patients after discharge from controlled in-patient
environments.
Those who died prematurely attracted significantly more diag-
noses related to injury, poisoning and other external causes;
however, these did not translate into high numbers of traumatic
deaths or completed suicides. Overall, those dying prematurely
received more physical health diagnoses across all listed ICD-10
blocks and spent significantly more days as general hospital in-
patients than those who remained alive evidencing the poorer phys-
ical state of that group.
Scotland does not have the healthiest national population,
indeed the ‘Scottish effect’ is much examined with 17 hypotheses
proposed to account for excessive premature mortality.44 We
suggest that something akin to the ‘Scottish effect’, specifically in
terms of biopsychosocial stress and the resultant physiological
stress response, is being observed among mainstream and forensic
psychiatric populations. High levels of adverse life events observed
among Scottish forensic patients45 together with the dose–response
association observed between adverse life events/psychological dis-
tress and a negative impact upon subjective and objective physical
health46 may be evidenced within our reported cohort. There is
increasing physiological evidence of heightened levels of oxidative
stress and inflammation within anxiety, depressive, bipolar disorder
and schizophrenia.36,47 These processes provide mechanistic path-
ways by which leucocyte telomere length can be shortened. Meta-
analysis has evidenced shortened telomere length across a range
of psychiatric disorders36 with length being an indicator of cell
ageing and short length associated with age-related morbidities,
for example immune dysregulation, cancer, diabetes and cardiovas-
cular disease.48 Interpreting the morbidity and excess mortality
observed in cohorts such as this through the lens of the ‘Scottish
effect’ may lead to better targeted local interventions.
Limitations
This study has several limitations. Follow-up physical health informa-
tion could only be requested for deceased or consented participants.
The wider study adopts a gatekeeper approach therefore all cohort
members whose gatekeeper denied access because of their inability
to provide ‘fair’ consent49 or they were not physically/mentally well
enough to be approached were excluded. This removed individuals
with the greatest physical health needs and/or the severest psychiatric
symptomatology. The mortality status of eight individuals remained
unknown although of these seven resided in Northern Ireland. We
could not locate or engage with appropriate Northern Ireland services
to confirm their status or locate their current care team. It proved
impossible to access information without consent. Accessing cohort
member gatekeepers within England was equally difficult but mortal-
ity information moved between NHSCR and their English counter-
parts. Some individuals with mortality status unknown could have
died because of suicide or accidental causes, raising our mortality
profile, but it would remain lower than the reported studies. We
were also as reliant on the general hospital clinicians accurately
recording and/or applying the most appropriate ICD-10 codes as
we were of the cohort member and their accompanying staff provid-
ing a precise physical health history.
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